Quick Answer
Medpace Holdings, Inc. reported Total Assets of $1.98 billion for the year ending 2025.
- Medpace Holdings, Inc. showed a decrease of -6.0% in Total Assets from 2024 to 2025.
- This data is from Medpace Holdings, Inc.'s annual report (Form 10-K), filed with the SEC on February 10, 2026.
- XBRL data for this metric is available from 2015 to 2025 (11 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2016: $976.49 million | Q1 2017: $966.09 million | Q2 2017: $963.65 million | Q3 2017: $948.88 million | Q1 2018: $973.02 million | Q2 2018: $968.18 million | Q3 2018: $949.84 million | Q1 2019: $1.01 billion | Q2 2019: $1.02 billion | Q3 2019: $1.07 billion | Q1 2020: $1.14 billion | Q2 2020: $1.22 billion | Q3 2020: $1.30 billion | Q1 2021: $1.45 billion | Q2 2021: $1.47 billion | Q3 2021: $1.58 billion | Q1 2022: $1.34 billion | Q2 2022: $1.32 billion | Q3 2022: $1.33 billion | Q1 2023: $1.40 billion | Q2 2023: $1.41 billion | Q3 2023: $1.49 billion | Q1 2024: $1.80 billion | Q2 2024: $1.92 billion | Q3 2024: $2.08 billion | Q1 2025: $1.90 billion | Q2 2025: $1.57 billion | Q3 2025: $1.75 billion.
- Over the full 11 years of available data (2015 to 2025), Medpace Holdings, Inc.'s Total Assets has grown by 100.8%.
- Historical annual values: Fiscal year 2025: $1.98 billion | Fiscal year 2024: $2.10 billion | Fiscal year 2023: $1.66 billion | Fiscal year 2022: $1.35 billion | Fiscal year 2021: $1.66 billion | Fiscal year 2020: $1.39 billion | Fiscal year 2019: $1.14 billion | Fiscal year 2018: $1.00 billion | Fiscal year 2017: $950.72 million | Fiscal year 2016: $979.11 million | Fiscal year 2015: $984.04 million.
- Data sourced from SEC EDGAR public filings as of August 4, 2026.
Last verified: